INSILICOTRIALS TECHNOLOGIES
Born in 2016, InSilicoTrials is a startup founded by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize healthcare through modeling & simulation. Today, the very long and expensive development and certification processes of new drugs and medical devices are becoming unsustainable. Simulation can reduce these costs up to 50% and greatly accelerate the go-to-market of new products. Regulatory agencies are pushing companies to adopt these practices, bu... t many of these lack the IT infrastructure, expensive software, and high expertise needed to develop and use models. InSilicoTrials solves these problems by collecting the best models available in universities worldwide and then embedding them in a scalable IT platform, which makes it easier to find the right model, use it without specific knowledge and pay for the resources you use. This is possible because the InSilicoTrials team covers a broad range of expertise in IT and cloud solutions, scientific data management, pharmaceutical and biomedical R&D. All InSilicoTrials models are validated to support the productโs approval by the regulatory. Scientists, researchers and clinicians can develop and run their own models or access the best models selected by the InSilicoTrials R&D team. Simulation is a key factor to cut in vitro and in vivo testing costs, accelerate the go-to-market of new drugs, and also to create custom-made medical devices instead of the standard-size devices that are implanted today and frequently cause problems. InSilicoTrials is the first cloud-based platform that provides healthcare companies and researchers with easy-to-use tools to perform complex computational modeling and simulation for drug and medical device development. This cutting-edge technology can increase the quality of life of millions of patients by allowing cheaper treatments, bringing innovative drugs to the market in a shorter time, together with personalized cures and new solutions for rare diseases.
INSILICOTRIALS TECHNOLOGIES
Industry:
Biotechnology Health Care Simulation Software
Founded:
2016-05-04
Address:
Trieste, Friuli-Venezia Giulia, Italy
Country:
Italy
Website Url:
http://www.insilicotrials.com
Total Employee:
11+
Status:
Active
Contact:
+39 02 84246328
Email Addresses:
[email protected]
Total Funding:
4.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
DVTK LTD
DVTk is an open source project for testing, validating and diagnosing communication protocols and scenarioโs in medical environments.
Inthera Bioscience
Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Molecular Health
Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.
Neuroelectrics
Neuroelectrics is a digital brain health company that diagnoses and treats brain disorders, and improves overall brain health.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
StartUp Health
StartUp Health investment in Seed Round - InSilicoTrials Technologies
Official Site Inspections
http://www.insilicotrials.com
- Host name: cloudproxy10079.sucuri.net
- IP address: 192.124.249.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "InSilicoTrials Technologies"
About us - InSilicoTrials
As a company with 16 employees representing 6 different nationalities, InSilicoTrials is committed to foster and deliver innovation through a diverse workforce and a fast-paced inclusive โฆSee details»
InSilicoTrials - Crunchbase Company Profile & Funding
InSilicoTrials is an emerging startup founded in 2018 by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize Healthcare through an innovative digital โฆSee details»
InSilicoTrials Company Profile 2025: Valuation, Funding
InSilicoTrials was founded in 2012. Where is InSilicoTrials headquartered? InSilicoTrials is headquartered in Trieste, Italy. What is the size of InSilicoTrials? InSilicoTrials has 33 total โฆSee details»
InSilicoTrials - LinkedIn
InSilicoTrials is a leading technology company revolutionizing drug development through AI-powered simulation. Our platform provides pharmaceutical and biotech companies with access โฆSee details»
InSilicoTrials - Company Profile - Tracxn
Dec 6, 2024 InSilicoTrials. has raised a total funding of $3.5M over 2 rounds. Its first funding round was on Jun 22, 2020. What are the most recent funding rounds of InSilicoTrials? Its โฆSee details»
Our Approach - InSilicoTrials
OUR APPROACH Simulations Made Easy and Cost-Effective Our aim is to democratize the healthcare industry, making Modeling & Simulation and AI accesible to big, small and mid-sized companies. Contact us A mix of experts โฆSee details»
InSilicoTrials Technologies - Org Chart, Teams, Culture & Jobs
InSilicoTrials is a web-based platform leveraging modeling and simulation to cut costs and timeline in drug and medical device development. Industries. Biotechnology, Health Care +1. โฆSee details»
InSilicoTrials - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 30, 2020: Grant - โฆSee details»
InSilicoTrials - United Ventures
Founded in 2017 in Trieste, InSilicoTrials offers a double-sided, cloud-based platform for modeling and simulation to help pharma and medical devices companies reducing time and cost for โฆSee details»
InSilicoTrials: accelerating the uptake of simulation in clinical โฆ
Feb 11, 2021 InSilicoTrials aims to solve this problem by collecting the best simulation models from universities and embedding them in a scalable IT cloud-based platform that can be used โฆSee details»
InSilicoTrials - Craft
Insilicotrials Technologies is a company developing a web-based platform that provides a user-friendly computational modeling and simulation environment. For the pharmaceutical sector, โฆSee details»
InSilicoTrials - Overview, News & Similar companies - ZoomInfo
Feb 12, 2024 Who is InSilicoTrials. InSilicoTrials is the first cloud-based platform for in silico clinical trials, built to provide healthcare companies and research centers with an integrated โฆSee details»
Our Partners - InSilicoTrials
InSilicoTrials is also a member of EMAโ s Consultative Working Group for Cloud Security . Scientific Partners. Our models are the result of the long and hard work of many researchers. โฆSee details»
InSilicoTrials Company Overview, Contact Details & Competitors
InSilicoTrials. IT Services and IT Consulting Delaware, United States 11-50 Employees. We are a game-changer in the life sciences sector. Our mission is to hyper-accelerate drug and medical โฆSee details»
InSilicoTrials - live.diaglobal.org
InSilicoTrials aims to become the premier problem solver in drug development by leveraging computational modeling and simulation (in silico) techniques. Using AI and advanced โฆSee details»
InSilicoTrials - Contacts, Employees, Board Members, Advisors
Modeling and Simulation to accelerate development and improve safety of drugs and medical devices and significantly cut R&D costs and timeSee details»
InSilicoTrials presents a suite of highly innovative products that ...
โInSilicoTrials was born with the aim of accelerating innovation in the medical sector, making it cheaper and more accessible,โ says Luca Emili, Founder and CEO of InSilicoTrials. โฆSee details»
InSilicoTrials Company Information - Funding, Investors, and More
The company InSilicoTrials has raised a total of $3.43m in funding over 1 rounds. Key Insights: Unknown: $3.43m; 2020. InSilicoTrials Unknown (2020, $3M) $3.43m. Discover Iwoca. โฆSee details»
InSilicoTrials: innovation through simulation - United Ventures
Jul 27, 2020 We are happy to announce our Series A in InSilicoTrials, a cloud-based platform for modeling & simulation that helps pharma and medical device companies to reduce time and โฆSee details»